SHANGHAI, Oct. 16, 2025 /PRNewswire/ — Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson’s disease (PD) and other neurological disorders, announced positive 6-month follow-up data from the first patient in its phase 1 […]
